Skip to main content

Table 2 Characteristics of patients with severe vs. life-threatening disease receiving COVID-19 convalescent plasma at time of transfusiona

From: Hospitalized COVID-19 patients treated with convalescent plasma in a mid-size city in the Midwest

  COVID-19 Classification  
  Severe Life-Threatening  
  n = 16 n = 15 pb
Female sex – no. (%) 7 (44) 3 (20) 0.252
BMI 37.3 ± 8.4 37.5 ± 12.6 0.964
Sequential Organ Failure Assessment (SOFA) Score 0 [1.5] 4 [2] 0.001
C-reactive protein – mg/dL 12.0 ± 9.8 19.5 ± 7.6 0.028
D-dimer – mcg/mL 1.86 ± 3.08 3.55 ± 4.96 0.271
Ferritin – ng/mL 1469 ± 1764 1594 ± 1018 0.821
In-Hospital Death – no. (%) 0 4 (27%) 0.037
Length of stay – days 9 [4] 21.5 [25.5] 0.012
  1. aPlus-minus values are means ± SD, values with brackets are medians [interquartile range]
  2. bFisher’s exact test, Student’s T-test, or Wilcoxon-Mann-Whitney test as appropriate